'Crazy hours, short nights': The inside story of how a buzzy biotech upstart developed a potential coronavirus vaccine in record time (MRNA)

· The $10 billion biotech Moderna developed a potential coronavirus vaccine in record time, zooming past Big Pharma competitors.
· The company's CEO Stephane Bancel sat down with Business Insider to discuss the technology platform that drove its speed, and how the company hopes to pioneer a new way of developing...